182 related articles for article (PubMed ID: 28968805)
1. A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense.
Svedin E; Utorova R; Hühn MH; Larsson PG; Stone VM; Garimella M; Lind K; Hägglöf T; Pincikova T; Laitinen OH; McInerney GM; Scholte B; Hjelte L; Karlsson MCI; Flodström-Tullberg M
J Infect Dis; 2017 Dec; 216(10):1308-1317. PubMed ID: 28968805
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations.
Lara-Reyna S; Holbrook J; Jarosz-Griffiths HH; Peckham D; McDermott MF
Cell Mol Life Sci; 2020 Nov; 77(22):4485-4503. PubMed ID: 32367193
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of acinar apoptosis occurs during acute pancreatitis in the human homologue DeltaF508 cystic fibrosis mouse.
DiMagno MJ; Lee SH; Owyang C; Zhou SY
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G400-12. PubMed ID: 20522641
[TBL] [Abstract][Full Text] [Related]
5. A defective flexible loop contributes to the processing and gating defects of the predominant cystic fibrosis-causing mutation.
Chen X; Zhu S; Zhenin M; Xu W; Bose SJ; Wong MP; Leung GPH; Senderowitz H; Chen JH
FASEB J; 2019 Apr; 33(4):5126-5142. PubMed ID: 30668920
[TBL] [Abstract][Full Text] [Related]
6. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW
Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses.
Bodas M; Mazur S; Min T; Vij N
Respir Res; 2018 Jan; 19(1):2. PubMed ID: 29301535
[TBL] [Abstract][Full Text] [Related]
8. DeltaF508-CFTR causes constitutive NF-kappaB activation through an ER-overload response in cystic fibrosis lungs.
Knorre A; Wagner M; Schaefer HE; Colledge WH; Pahl HL
Biol Chem; 2002 Feb; 383(2):271-82. PubMed ID: 11934265
[TBL] [Abstract][Full Text] [Related]
9. The ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice.
Fontés G; Ghislain J; Benterki I; Zarrouki B; Trudel D; Berthiaume Y; Poitout V
Diabetes; 2015 Dec; 64(12):4112-22. PubMed ID: 26283735
[TBL] [Abstract][Full Text] [Related]
10. Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells?
Hampton TH; Ballok AE; Bomberger JM; Rutkowski MR; Barnaby R; Coutermarsh B; Conejo-Garcia JR; O'Toole GA; Stanton BA
Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(6):L509-18. PubMed ID: 22821996
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis.
Bali V; Lazrak A; Guroji P; Matalon S; Bebok Z
PLoS One; 2016; 11(5):e0155882. PubMed ID: 27214033
[TBL] [Abstract][Full Text] [Related]
12. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
13. A genomic signature approach to rescue ΔF508-cystic fibrosis transmembrane conductance regulator biosynthesis and function.
Ramachandran S; Osterhaus SR; Karp PH; Welsh MJ; McCray PB
Am J Respir Cell Mol Biol; 2014 Sep; 51(3):354-62. PubMed ID: 24669817
[TBL] [Abstract][Full Text] [Related]
14. The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential.
Bodas M; Vij N
Discov Med; 2010 Apr; 9(47):346-56. PubMed ID: 20423679
[TBL] [Abstract][Full Text] [Related]
15. The DeltaF508 mutation results in loss of CFTR function and mature protein in native human colon.
Mall M; Kreda SM; Mengos A; Jensen TJ; Hirtz S; Seydewitz HH; Yankaskas J; Kunzelmann K; Riordan JR; Boucher RC
Gastroenterology; 2004 Jan; 126(1):32-41. PubMed ID: 14699484
[TBL] [Abstract][Full Text] [Related]
16. Disease-causing mutations in the cystic fibrosis transmembrane conductance regulator determine the functional responses of alveolar macrophages.
Deriy LV; Gomez EA; Zhang G; Beacham DW; Hopson JA; Gallan AJ; Shevchenko PD; Bindokas VP; Nelson DJ
J Biol Chem; 2009 Dec; 284(51):35926-38. PubMed ID: 19837664
[TBL] [Abstract][Full Text] [Related]
17. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.
Persu A; Devuyst O; Lannoy N; Materne R; Brosnahan G; Gabow PA; Pirson Y; Verellen-Dumoulin C
J Am Soc Nephrol; 2000 Dec; 11(12):2285-2296. PubMed ID: 11095651
[TBL] [Abstract][Full Text] [Related]
18. AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis.
Johnson JS; Gentzsch M; Zhang L; Ribeiro CM; Kantor B; Kafri T; Pickles RJ; Samulski RJ
PLoS Pathog; 2011 May; 7(5):e1002053. PubMed ID: 21625534
[TBL] [Abstract][Full Text] [Related]
19. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
[TBL] [Abstract][Full Text] [Related]
20. Haplotype analysis of the CFTR gene on normal and mutant CFTR genes.
Karimi N; Bidemeshki Pour A; Alibakhshi R; Almasi S
Mutat Res; 2020; 821():111708. PubMed ID: 32563932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
